+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Stroke - Pipeline Review, H2 2019

  • ID: 4866528
  • Drug Pipelines
  • 673 pages
  • Global Markets Direct
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 3

FEATURED COMPANIES

  • Acorda Therapeutics Inc
  • Avilex Pharma ApS
  • Epygen Biotech Pvt Ltd
  • Meridigen Biotech Co Ltd
  • Pharmagenesis Inc
  • Shionogi & Co Ltd
  • MORE
Stroke - Pipeline Review, H2 2019

Summary

This latest Pharmaceutical and Healthcare disease pipeline guide Stroke - Pipeline Review, H2 2019, provides an overview of the Stroke (Cardiovascular) pipeline landscape.

Stroke is a condition in which the brain cells suddenly die because of a lack of oxygen. Symptoms occur rapidly and usually last a short time, from a few minutes to a couple of hours. The symptoms of a stroke usually appear suddenly. Initially the person may feel sick, and look pale and very unwell. They may complain of a sudden headache. They may have sudden numbness in their face or limbs, particularly down one side of their body. They may appear confused and have trouble talking or understanding what is being said to them. They may have vision problems, and trouble walking or keeping their balance.

Report Highlights

This Pharmaceutical and Healthcare latest pipeline guide Stroke - Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Stroke (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Stroke (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Stroke and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Phase 0, IND/CTA Filed, Preclinical, Discovery and Unknown stages are 1, 13, 33, 24, 1, 3, 122, 17 and 2 respectively. Similarly, the Universities portfolio in Phase III, Preclinical and Discovery stages comprises 1, 31 and 5 molecules, respectively.

Stroke (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher'sproprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope
  • The pipeline guide provides a snapshot of the global therapeutic landscape of Stroke (Cardiovascular).
  • The pipeline guide reviews pipeline therapeutics for Stroke (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Stroke (Cardiovascular) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Stroke (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Stroke (Cardiovascular)
Reasons to buy
  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Stroke (Cardiovascular).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Stroke (Cardiovascular) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Acorda Therapeutics Inc
  • Avilex Pharma ApS
  • Epygen Biotech Pvt Ltd
  • Meridigen Biotech Co Ltd
  • Pharmagenesis Inc
  • Shionogi & Co Ltd
  • MORE
Introduction
Stroke - Overview
Stroke - Therapeutics Development
Stroke - Therapeutics Assessment
Stroke - Companies Involved in Therapeutics Development
Stroke - Drug Profiles
Stroke - Dormant Projects
Stroke - Discontinued Products
Stroke - Product Development Milestones
Appendix

List of Tables
Table 1: Number of Products under Development for Stroke, H2 2019
Table 2: Number of Products under Development by Companies, H2 2019
Table 3: Number of Products under Development by Companies, H2 2019 (Contd..1), H2 2019
Table 4: Number of Products under Development by Companies, H2 2019 (Contd..2), H2 2019
Table 5: Number of Products under Development by Companies, H2 2019 (Contd..3), H2 2019
Table 6: Number of Products under Development by Companies, H2 2019 (Contd..4), H2 2019
Table 7: Number of Products under Development by Companies, H2 2019 (Contd..5), H2 2019
Table 8: Number of Products under Development by Companies, H2 2019 (Contd..6), H2 2019
Table 9: Number of Products under Development by Companies, H2 2019 (Contd..7), H2 2019
Table 10: Number of Products under Development by Companies, H2 2019 (Contd..8), H2 2019
Table 11: Number of Products under Development by Companies, H2 2019 (Contd..9), H2 2019
Table 12: Number of Products under Development by Universities/Institutes, H2 2019
Table 13: Number of Products under Development by Universities/Institutes, H2 2019 (Contd..1), H2 2019
Table 14: Products under Development by Companies, H2 2019
Table 15: Products under Development by Companies, H2 2019 (Contd..1), H2 2019
Table 16: Products under Development by Companies, H2 2019 (Contd..2), H2 2019
Table 17: Products under Development by Companies, H2 2019 (Contd..3), H2 2019
Table 18: Products under Development by Companies, H2 2019 (Contd..4), H2 2019
Table 19: Products under Development by Companies, H2 2019 (Contd..5), H2 2019
Table 20: Products under Development by Companies, H2 2019 (Contd..6), H2 2019
Table 21: Products under Development by Companies, H2 2019 (Contd..7), H2 2019
Table 22: Products under Development by Companies, H2 2019 (Contd..8), H2 2019
Table 23: Products under Development by Companies, H2 2019 (Contd..9), H2 2019
Table 24: Products under Development by Companies, H2 2019 (Contd..10), H2 2019
Table 25: Products under Development by Companies, H2 2019 (Contd..11), H2 2019
Table 26: Products under Development by Universities/Institutes, H2 2019
Table 27: Products under Development by Universities/Institutes, H2 2019 (Contd..1), H2 2019
Table 28: Number of Products by Stage and Target, H2 2019
Table 29: Number of Products by Stage and Target, H2 2019 (Contd..1), H2 2019
Table 30: Number of Products by Stage and Target, H2 2019 (Contd..2), H2 2019
Table 31: Number of Products by Stage and Target, H2 2019 (Contd..3), H2 2019
Table 32: Number of Products by Stage and Target, H2 2019 (Contd..4), H2 2019
Table 33: Number of Products by Stage and Target, H2 2019 (Contd..5), H2 2019
Table 34: Number of Products by Stage and Mechanism of Action, H2 2019
Table 35: Number of Products by Stage and Mechanism of Action, H2 2019 (Contd..1), H2 2019
Table 36: Number of Products by Stage and Mechanism of Action, H2 2019 (Contd..2), H2 2019
Table 37: Number of Products by Stage and Mechanism of Action, H2 2019 (Contd..3), H2 2019
Table 38: Number of Products by Stage and Mechanism of Action, H2 2019 (Contd..4), H2 2019
Table 39: Number of Products by Stage and Mechanism of Action, H2 2019 (Contd..5), H2 2019
Table 40: Number of Products by Stage and Route of Administration, H2 2019
Table 41: Number of Products by Stage and Molecule Type, H2 2019
Table 42: Stroke - Pipeline by Acorda Therapeutics Inc, H2 2019
Table 43: Stroke - Pipeline by Acticor Biotech SAS, H2 2019
Table 44: Stroke - Pipeline by Addex Therapeutics Ltd, H2 2019
Table 45: Stroke - Pipeline by advanceCor GmbH, H2 2019
Table 46: Stroke - Pipeline by AegisCN LLC, H2 2019
Table 47: Stroke - Pipeline by Aegle Therapeutics Corp, H2 2019
Table 48: Stroke - Pipeline by Affibody AB, H2 2019
Table 49: Stroke - Pipeline by Allife Medical Science and Technology Co Ltd, H2 2019
Table 50: Stroke - Pipeline by Allosteros Therapeutics Inc, H2 2019
Table 51: Stroke - Pipeline by Amarantus Bioscience Holdings Inc, H2 2019
Table 52: Stroke - Pipeline by Anavex Life Sciences Corp, H2 2019
Table 53: Stroke - Pipeline by Ankasa Regenerative Therapeutics Inc, H2 2019
Table 54: Stroke - Pipeline by Annovis Bio Inc, H2 2019
Table 55: Stroke - Pipeline by AntiRadical Therapeutics LLC, H2 2019
Table 56: Stroke - Pipeline by Antoxis Ltd, H2 2019
Table 57: Stroke - Pipeline by Apellis Pharmaceuticals Inc, H2 2019
Table 58: Stroke - Pipeline by Aposcience AG, H2 2019
Table 59: Stroke - Pipeline by APT Therapeutics Inc, H2 2019
Table 60: Stroke - Pipeline by AptaTargets SL, H2 2019

List of Figures
Figure 1: Number of Products under Development for Stroke, H2 2019
Figure 2: Number of Products under Development by Companies, H2 2019
Figure 3: Number of Products under Development by Universities/Institutes, H2 2019
Figure 4: Number of Products by Top 10 Targets, H2 2019
Figure 5: Number of Products by Stage and Top 10 Targets, H2 2019
Figure 6: Number of Products by Top 10 Mechanism of Actions, H2 2019
Figure 7: Number of Products by Stage and Top 10 Mechanism of Actions, H2 2019
Figure 8: Number of Products by Top 10 Routes of Administration, H2 2019
Figure 9: Number of Products by Stage and Top 10 Routes of Administration, H2 2019
Figure 10: Number of Products by Top 10 Molecule Types, H2 2019
Figure 11: Number of Products by Stage and Top 10 Molecule Types, H2 2019
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Acorda Therapeutics Inc
  • Acticor Biotech SAS
  • Addex Therapeutics Ltd
  • advanceCor GmbH
  • AegisCN LLC
  • Aegle Therapeutics Corp
  • Affibody AB
  • Allife Medical Science and Technology Co Ltd
  • Allosteros Therapeutics Inc
  • Amarantus Bioscience Holdings Inc
  • Anavex Life Sciences Corp
  • Ankasa Regenerative Therapeutics Inc
  • Annovis Bio Inc
  • AntiRadical Therapeutics LLC
  • Antoxis Ltd
  • Apellis Pharmaceuticals Inc
  • Aposcience AG
  • APT Therapeutics Inc
  • AptaTargets SL
  • Aranda Pharma Ltd
  • AriBio
  • ArmaGen Inc
  • Aronora Inc
  • Artelo Biosciences Inc
  • ArunA Biomedical Inc
  • Asta Pharmaceuticals Co Ltd
  • AstraZeneca Plc
  • Athersys Inc
  • Avilex Pharma ApS
  • Axolo Pharma Inc
  • Band Therapeutics LLC
  • Beijing Yinfeng Dingcheng Bioengineering Co Ltd
  • BioAxone BioSciences Inc
  • Biogen Inc
  • Boehringer Ingelheim International GmbH
  • Brain-Gen LLC
  • Bristol-Myers Squibb Co
  • CardioVascular BioTherapeutics Inc
  • Celltrion Inc
  • Cenyx Biotech Inc
  • Cerebrum Therapeutics Inc
  • CHA Bio & Diostech Co Ltd
  • China Resources Emde Biological Pharmaceutical Co Ltd
  • Cogentis Therapeutics Inc
  • CohBar Inc
  • Constant Therapeutics LLC
  • CSPC Pharmaceutical Group Ltd
  • Curacle Co Ltd
  • CuroNZ Ltd
  • Daewoong Pharmaceutical Co Ltd
  • Daiichi Sankyo Co Ltd
  • Deha Pharmaceutical LLC
  • DiaMedica Therapeutics Inc
  • Diffusion Pharmaceuticals Inc
  • Edvince AB
  • EIP Pharma LLC
  • Epigen Biosciences Inc
  • Epygen Biotech Pvt Ltd
  • Ever Supreme Bio Technology Co Ltd
  • Evgen Pharma Plc
  • eXithera Pharmaceuticals Inc
  • Exscien Corp
  • F. Hoffmann-La Roche Ltd
  • Fortuna Fix Inc
  • Freeox Biotech SL
  • Fujifilm Toyama Chemical Co Ltd
  • GABA Therapeutics Inc
  • Genervon Biopharmaceuticals LLC
  • Glialogix Inc
  • Glucox Biotech AB
  • GNT Pharma Co Ltd
  • Guangzhou Cellprotek Pharmaceutical Co Ltd
  • Guangzhou Magpie Pharmaceutical Co Ltd
  • Guangzhou Recomgen Biotech Co Ltd
  • Guangzhou-Sheng Jian Chi Pharmaceutical Co Ltd
  • Gwoxi Stem Cell Applied Technology Co Ltd
  • Hefei Industrial Pharmaceutical Institute Co Ltd
  • Hibernaid Inc
  • Hillhurst Biopharmaceuticals Inc
  • Hope Biosciences LLC
  • HSRx Group
  • Immunwork Inc
  • Instituto Biomar SA
  • International Stem Cell Corp
  • JCR Pharmaceuticals Co Ltd
  • Jeil Pharmaceutical Co Ltd
  • Jiangsu Ouwei Pharmaceutical Co Ltd
  • JT Pharmaceuticals Inc
  • Kai Nuo Bio Sci Co Ltd
  • Kyoto Drug Discovery & Development Co Ltd
  • Les Laboratoires Servier SAS
  • Lineage Cell Therapeutics Inc
  • Living Cell Technologies Ltd
  • Lixte Biotechnology Holdings Inc
  • LTT Bio-Pharma Co Ltd
  • Lumosa Therapeutics Co Ltd
  • M et P Pharma AG
  • Mapreg SAS
  • Marizyme Inc
  • Meridigen Biotech Co Ltd
  • Mitoconix Bio Ltd
  • Modulation Therapeutics Inc
  • NC Medical Research Inc
  • NeoCytex Biopharma Inc
  • NeuExcell Therapeutics Inc
  • Neuraly Inc
  • Neuren Pharmaceuticals Ltd
  • NeurExo Sciences LLC
  • NeuroActiva Inc
  • Neurodon LLC
  • NeuroFix Therapeutics LLC
  • NeuroNascent Inc
  • NeurOp Inc
  • Neurotrope Bioscience Inc
  • New World Laboratories Inc
  • Nipro Corp
  • NoNO Inc
  • Novago Therapeutics AG
  • Novartis AG
  • NuvOx Pharma LLC
  • Nyrada Inc
  • Omniox Inc
  • OTR3 SAS
  • Paracelsus Neuroscience I LLC
  • Park Active Molecules
  • Pharmagenesis Inc
  • PharmatrophiX Inc
  • Pharmazz Inc
  • Pharmicell Co Ltd
  • Phoenix Biotechnology Inc
  • PhytoHealth Corp
  • Prediction BioSciences SAS
  • Primary Peptides Inc
  • Q Therapeutics Inc
  • Regenera Pharma Ltd
  • Regeneron Pharmaceuticals Inc
  • RegeneRx Biopharmaceuticals Inc
  • ReNetX Bio
  • ReNeuron Group Plc
  • Rich Pharmaceuticals Inc
  • Rubicon Biotechnology Inc
  • Saje Pharma LLC
  • SanBio Inc
  • Saneron CCEL Therapeutics Inc
  • Saniona AB
  • Sansho Co Ltd
  • Savara Inc
  • Seneca Biopharma Inc
  • Sentan Pharma Inc
  • Shanghai Angecon Biotechnology Corp
  • Shanghai SIMR Biotech Co Ltd
  • Shin Poong Pharm Co Ltd
  • Shionogi & Co Ltd
  • Simcere Pharmaceutical Group
  • Stemedica Cell Technologies Inc
  • Stemetix Inc
  • Stream Biomedical Inc
  • SunBio Inc
  • Suzhou Pharmavan Cancer Research Center Co Ltd
  • TaiGen Biotechnology Co Ltd
  • Tasly Pharmaceutical Group Co Ltd
  • Techfields Pharma Co Ltd
  • Tenax Therapeutics Inc
  • The Cell Factory BVBA
  • TheraSource LLC
  • Theratome Bio Inc
  • Thrombolytic Science International LLC
  • TikoMed AB
  • TMS Co Ltd
  • Translational Sciences Inc
  • Valin Technologies Ltd
  • Vect-Horus SAS
  • Verseon Corp
  • Virogenomics BioDevelopment Inc
  • Virtici LLC
  • WhanIn Pharmaceutical Co Ltd
  • Xcelthera INC
  • Xonovo Inc
  • Yantai YenePharma Co Ltd
  • Zensun (Shanghai) Sci & Tech Co Ltd
  • Zhejiang Ausun Pharmaceutical Co Ltd
  • Zocere Inc
  • ZyVersa Therapeutics Inc
  • ZZ Biotech LLC
Note: Product cover images may vary from those shown
Adroll
adroll